Maged F. Khalil, MD

Dr. Maged Khalil, MD

Claim this profile

Lehigh Valley Health Network

Studies Solid Tumors
Studies Cancer
5 reported clinical trials
26 drugs studied

Area of expertise

1

Solid Tumors

Maged Khalil, MD has run 2 trials for Solid Tumors. Some of their research focus areas include:

Stage III
MMR positive
MSI positive
2

Cancer

Maged Khalil, MD has run 2 trials for Cancer. Some of their research focus areas include:

Stage III
MMR positive
MSI positive

Affiliated Hospitals

Image of trial facility.

Lehigh Valley Health Network (Data Collection Only)

Image of trial facility.

Lehigh Valley Health Network

Clinical Trials Maged Khalil, MD is currently running

Image of trial facility.

Targeted Therapy

for Advanced Stage Cancer

The purpose of the study is to learn from the real world practice of prescribing targeted therapies to patients with advanced cancer whose tumor harbors a genomic variant known to be a drug target or to predict sensitivity to a drug. NOTE: Due to character limits, the arms section does NOT include all TAPUR Study relevant biomarkers. For additional information, contact TAPUR@asco.org, or if a patient, your nearest participating TAPUR site (see participating centers). \*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\* Results in publication or poster presentation format are posted as they become available for individual cohorts at www.tapur.org/news. The results may be accessed at any time. All results will be made available on clinicaltrials.gov at the end of the study. Indexing of available results on PubMed is in progress. \*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*

Recruiting

1 award

Phase 2

9 criteria

Image of trial facility.

PD-1 Blockade + Chemoradiation

for Cancer

The purpose of this study is to find out whether the study drug, TSR-042, followed by standard chemoradiotherapy (the chemotherapy drug capecitabine + radiation therapy) and standard surgery is an effective treatment for advanced dMMR solid tumors. The study will also look at the safety of the study drug.

Recruiting

1 award

Phase 2

27 criteria

More about Maged Khalil, MD

Clinical Trial Related

8 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 3 Active Clinical Trials

Treatments Maged Khalil, MD has experience with

  • Pembrolizumab
  • Nivolumab
  • TSR-042
  • Enfortumab Vedotin
  • Cabazitaxel
  • Ipilimumab

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?

What does Maged Khalil, MD specialize in?

Is Maged Khalil, MD currently recruiting for clinical trials?

Are there any treatments that Maged Khalil, MD has studied deeply?

What is the best way to schedule an appointment with Maged Khalil, MD?

What is the office address of Maged Khalil, MD?

Is there any support for travel costs?